XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENT INFORMATION (Tables)
9 Months Ended
Jul. 31, 2024
Segment Reporting [Abstract]  
Segment Profitability and Segment Assets
The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:
Three Months EndedNine Months Ended
 July 31,July 31,
 2024202320242023
 (in millions)
Net Revenue:
Life Sciences and Applied Markets$782 $854 $2,382 $2,671 
Diagnostics and Genomics385 422 1,209 1,310 
Agilent CrossLab411 396 1,218 1,164 
Total net revenue$1,578 $1,672 $4,809 $5,145 
Segment Income From Operations:
Life Sciences and Applied Markets$222 $265 $644 $809 
Diagnostics and Genomics70 96 226 262 
Agilent CrossLab140 129 385 335 
Total segment income from operations$432 $490 $1,255 $1,406 
The following table reflects segment and unallocated assets. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets.  
 July 31,
2024
October 31,
2023
(in millions)
Assets:  
Life Sciences and Applied Markets$3,106 $3,161 
Diagnostics and Genomics3,986 3,966 
Agilent CrossLab916 897 
Unallocated Assets2,988 2,739 
Total assets$10,996 $10,763 
Reconciliation of segment results to total enterprise results
The following table reconciles segment income from operations to Agilent’s total enterprise income before taxes: 
Three Months EndedNine Months Ended
 July 31,July 31,
 2024202320242023
 (in millions)
Total segment income from operations$432 $490 $1,255 $1,406 
Unallocated costs:
Amortization of intangible assets related to business combinations(25)(38)(77)(112)
Acquisition and integration costs(4)(5)(5)(12)
Transformational initiatives(1)(19)(5)(31)
Asset impairment— (277)(8)(277)
Change in fair value of contingent consideration— — — (1)
Restructuring and other related costs(67)— (71)— 
Other(2)(18)(9)(31)
Total unallocated costs(99)(357)(175)(464)
Income from operations333 133 1,080 942 
Interest income19 13 56 34 
Interest expense(22)(24)(64)(73)
Other income (expense), net (1)
13 10 48 16 
Income before taxes, as reported$343 $132 $1,120 $919 
(1) For the nine months ended July 31, 2024, other income (expense), net includes primarily income related to foreign currency translation reclassified out of accumulated comprehensive income (loss) and the defined benefit retirement and post-retirement benefit plans.